Yiming Sun
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Identification of 46,XX/46,XY chimerism in a normal fertile male by low-pass copy number variation sequencing and NGS-based STR tests.
Journal: Journal of assisted reproduction and genetics
Published: March 31, 2026
Frozen versus fresh embryo transfer in low responders: a systematic review.
Journal: Fertility and sterility
Published: November 03, 2025
Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related Disorders.
Journal: Degenerative neurological and neuromuscular disease
Published: September 20, 2025
Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Journal: Molecular cancer
Published: August 19, 2023
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma.
Journal: Acta pharmaceutica Sinica. B
Published: May 14, 2023
Bi-allelic variants in ASTL cause abnormal fertilization or oocyte maturation defects.
Journal: Human molecular genetics
Published: April 04, 2023
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer.
Journal: Acta pharmaceutica Sinica. B
Published: December 21, 2022
The PROTAC selectively degrading Bcl-xL represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while sparing bone growth.
Journal: Theranostics
Published: May 23, 2022
Design, Synthesis, and Pharmacological Evaluation of Biaryl-Containing PD-1/PD-L1 Interaction Inhibitors Bearing a Unique Difluoromethyleneoxy Linkage.
Journal: Journal of medicinal chemistry
Published: November 11, 2021
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Journal: Molecular cancer
Published: August 18, 2021
Discovery of a Pyrimidinedione Derivative as a Potent and Orally Bioavailable Axl Inhibitor.
Journal: Journal of medicinal chemistry
Published: March 18, 2021
Last Updated: 09/26/2026